Proactive Investors - Run By Investors For Investors

OncoCyte releases positive data on lung cancer diagnostic study

OncoCyte Corporation (NYSE:OCX) CEO William Annett sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Annett says recently, OncoCyte released positive data on its lung cancer diagnostic study.

 
View full OCX profile View Profile

OncoCyte Corporation Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use